Arkolith/Insider Trading/FDMT/Form 4

Bizily Scott

Chief Legal Officer4D Molecular Therapeutics, Inc. (FDMT) · full profile →Form 4 · filed Nov 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)2K$4.14$7K5K
Nov 17, 2025Sell(S)2K$10.59$17K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2025Option exercise(M)2K—$075K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-288632) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML